Impact of BRCA mutations on outcomes among patients with serous endometrial cancer-Reference-Cited by-同舟云学术

Impact of BRCA mutations on outcomes among patients with serous endometrial cancer

Published:2018-04-02 Issue:1 Volume:142 Page:91-96
ISSN:0020-7292
Container-title:International Journal of Gynecology & Obstetrics
language:en
Short-container-title:Int J Gynecol Obstet

Author:

Kadan Yfat¹,Raviv Oshrat¹,Segev Yakir²,Lavie Ofer²,Bruchim Ilan³,Fishman Ami¹,Michaelson Rachel⁴⁵,Beller Uzi⁴,Helpman Limor¹⁶

Affiliation:

1. Gynecologic Oncology Division; Department of Obstetrics and Gynecology; Meir Medical Center; Kefar Sava Israel

2. Department of Obstetrics and Gynecology; Gynecologic Oncology Service; Carmel Medical Center; Haifa Israel

3. Department of Obstetrics and Gynecology; Hillel Yaffe Medical Center; Hadera Israel

4. Department of Obstetrics and Gynecology; Shaare Zedek Medical Center; Jerusalem Israel

5. Department of Genetics; Shaare Zedek Medical Center; Jerusalem Israel

6. Division of Gynecologic Oncology; Juravinski Cancer Center; McMaster University; Hamilton ON Canada

Publisher

Wiley

Subject

Obstetrics and Gynaecology,General Medicine

Reference21 articles.

1. Uterine papillary serous cancer: A review of the literature;Carmen;Gynecol Oncol,2012

2. An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas;Zhang;Int J Gynecol Pathol,2013

3. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas;Usach;Am J Obstet Gynecol,2015

4. NCCN guidelines version 2.2016. Genetic/familial high risk assessment: breast and ovarian https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf

5. Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response;De Picciotto;Crit Rev Oncol Hematol,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis;BMC Genomic Data;2024-01-31

2. Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be done;International Journal of Gynecologic Cancer;2023-11-02

3. Preoperative screening endometrial cytology discovered incidental gynaecological malignancy in two patients undergoing risk-reducing salpingo-oophorectomy;BMJ Case Reports;2023-03

4. Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives;Healthcare;2023-02-15

5. Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer;JAMA Oncology;2022-09-01